NCT06031454View on ClinicalTrials.gov

Drug-durg Interaction of Leritrelvir(RAY1216) With Midazolam, Omeprazole, Rosuvastatin, Verapamil, and Rifampin

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

November 1, 2023

Study Completion Date

December 31, 2023

Conditions

Drug Drug Interaction

Interventions

DRUG

Midazolam

oral

DRUG

Omeprazole

oral

DRUG

Rosuvastatin

oral

DRUG

Verapamil

oral

DRUG

Rifampin

oral

DRUG

Leritrelvir

oral

Trial Locations (1)

Unknown

the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors

lead

Guangdong Raynovent Biotech Co., Ltd

INDUSTRY

NCT06031454 - Drug-durg Interaction of Leritrelvir(RAY1216) With Midazolam, Omeprazole, Rosuvastatin, Verapamil, and Rifampin | Biotech Hunter | Biotech Hunter